[4] https://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-adults/prostate-cancer [5] https://www.cancerhealth.com/article/explaining-psa-numbers-risk-prostate-cancer [6] 2023 CSCO.前列腺癌诊疗指南 [7] Tourinho-Barbosa, R., Srougi, V., Nunes-Silva, I., Baghdadi, M...
Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, which NCI conducted to determine whether certain screening tests can help reduce the numbers of deaths from several common cancers. In the prostate portion of th...
The numbers of performed serum PSA tests, cost evolution, and utilization patterns by various subspecialties in one medical center were analyzed to gain insight into trends in screening for early detection of prostate cancer and gather information about the appropriate use of PSA testing. METHOD: ...
The non-synonymous KLK3 single nucleotide polymorphism (SNP), rs17632542 (c.536 T > C; Ile163Thr-substitution in PSA) is associated with reduced prostate cancer risk, however, the functional relevance is unknown. Here, we identify that the SNP variant-induced change in PSA biochemical...
Study: PSA level changes important; Prostate cancer fatality rate seems linked to how rapidly test numbers fluctuateASSOCIATED PRESS
Standard therapies for the primary treatment of localized prostate cancer routinely include surgery (prostatectomy), radiation therapy through brachytherapy (interstitial seed implants), or 3-dimensional conformational radiation therapy. In patients treated with surgery, prostate-specific antigen (PSA), a bio...
Effect of the Cluster randomized trial of PSA testing for Prostate cancer (CAP) trial intervention on the cumulative incidence of all-cause mortality eFigure 7. Cumulative incidence of prostate cancer in intervention-group non-attenders for PSA screening vs controls (A) and in the post-screening...
Purified PSA+ (i.e., GFP+DsReD+) and PSA−/lo (GFP−DsRed+) cells at the indicated numbers were injected subcutaneously into the intact or castrated male mice. All tumors were harvested in 2–3 months. c PSA+ (i.e., GFP+) and PSA−/lo (i.e., GFP−/lo) LAPC9 cells ...
After surgery or radiation, medical providers watch for a cancer relapse with PSA and PSADT test results. Those numbers plus your original risk category are considered together when deciding what treatment course to follow—the faster the PSADT and the higher your risk category, the more aggressive...
Screening for prostate cancer continues to generate controversy because of concerns about over-diagnosis and unnecessary treatment. We describe the rationale, design and recruitment of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)